GCPGC in Chemotherapy-induced Neutropenia
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-04-05
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 177
- Registration Number
- NCT01328938
- Locations
- ๐ฐ๐ท
Inha University Hospital, Seoul, Korea, Republic of
๐ฐ๐ทPusan National University Hospital, Pusan, Korea, Republic of
๐ฐ๐ทKyung Hee University Medical Center, Seoul, Korea, Republic of
GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock
- First Posted Date
- 2011-03-15
- Last Posted Date
- 2013-04-30
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 214
- Registration Number
- NCT01315496
- Locations
- ๐ฐ๐ท
Kangdong Sacred Heart Hospital, Seoul, Korea, Republic of
๐ฐ๐ทGyrongsang National University Hospital, Jinju-si, Gyeongsangnam-do,, Korea, Republic of
๐ฐ๐ทKangnam Sacred Heart Hospital, Seoul, Korea, Republic of
To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-02-23
- Last Posted Date
- 2012-02-14
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 31
- Registration Number
- NCT01301898
- Locations
- ๐ฐ๐ท
Samsung Medical Center, Seoul, Irwon-dong, Gangnam-Gu, Korea, Republic of
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-09-15
- Last Posted Date
- 2010-09-20
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 592
- Registration Number
- NCT01201902
ยฉ Copyright 2024. All Rights Reserved by MedPath